The Division of Neonatal and Developmental Medicine at Stanford University submits a competing renewal application to participate in the Cooperative Multicenter Network of Neonatal Intensive Care Units (Network). The Division and its faculty have a long history of innovative basic and clinical research accomplishments in neonatal medicine. This expertise dovetails with the Network goal of rigorous evaluation of treatment and management strategies through multicenter observational studies and interventional trials. As a participant in the last four grant cycles, this center has proven to be a strong and highly productive asset, contributing extensively to study design, protocol development, execution, analysis and results dissemination. Led by PI Krisa Van Meurs, Alternate PI David Stevenson, and Follow-up PI Susan Hintz, the site neonatologists are an exceptional group of faculty with wide-ranging expertise and extensive clinical research experience. For decades, neonatal research was facilitated within the General Clinical Research Center now replaced by Spectrum, funded by a Clinical and Translational Science Award. Dr. Stevenson is co-Director and Leader of Spectrum Child Health (SCH). SCH provides a milieu encouraging collaboration between basic and clinical scientists, and fosters the development of new investigators. Dr. Van Meurs is on the Executive Committee and Associate Chair for Clinical Research. Stanford has an outstanding history of preparing neonatologists for academic careers. Dr. Stevenson is PI for the Developmental and Neonatal Biology Training program and Drs. Hintz and Davis, graduates of this program, are recipients of the Mentored Specialized Clinical Investigator Development Award. Both have taken leading roles in development and execution of Network protocols. The framework of the Johnson Center for Pregnancy and Newborn Services facilitates close administrative, academic, and clinical collaboration between the Divisions of Neonatal and Developmental Medicine and Maternal Fetal Medicine. In summary, the Division of Neonatal and Developmental Medicine has the neonatal and subspecialty faculty, physical space, research resources, professional staff, and patient population necessary to continue as one of the finest centers participating in the Network.
Rapid advances in neonatal care have been made possible by academic medical centers working together to perform clinical studies to answer critical questions. Our concept addresses bronchopulmonary dysplasia (BPD), a common chronic lung condition seen in surviving premature infants and persisting into later life. We propose a trial of WJO treatments, inhaled nitric oxide and late surfactant, to efficiently determine if either results in reduced mortality or BPD in infants who have a high likelihood of these outcomes.
|Weissman, Scott J; Hansen, Nellie I; Zaterka-Baxter, Kristen et al. (2016) Emergence of Antibiotic Resistance-Associated Clones Among Escherichia coli Recovered From Newborns With Early-Onset Sepsis and Meningitis in the United States, 2008-2009. J Pediatric Infect Dis Soc 5:269-76|
|Wortham, Jonathan M; Hansen, Nellie I; Schrag, Stephanie J et al. (2016) Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections. Pediatrics 137:|
|Phelps, Dale L; Ward, Robert M; Williams, Rick L et al. (2016) Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants. Pediatr Res 80:209-17|
|Meyers, J M; Bann, C M; Stoll, B J et al. (2016) Neurodevelopmental outcomes in postnatal growth-restricted preterm infants with postnatal head-sparing. J Perinatol 36:1116-1121|
|Archer, Stephanie Wilson; Carlo, Waldemar A; Truog, William E et al. (2016) Improving publication rates in a collaborative clinical trials research network. Semin Perinatol 40:410-417|
|D'Angio, Carl T; Ambalavanan, Namasivayam; Carlo, Waldemar A et al. (2016) Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants. J Pediatr 174:45-51.e5|
|Pedroza, Claudia; Tyson, Jon E; Das, Abhik et al. (2016) Advantages of Bayesian monitoring methods in deciding whether and when to stop a clinical trial: an example of a neonatal cooling trial. Trials 17:335|
|Davis, A S; Gantz, M G; Do, B et al. (2015) Serial aEEG recordings in a cohort of extremely preterm infants: feasibility and safety. J Perinatol 35:373-8|
|Rysavy, Matthew A; Li, Lei; Bell, Edward F et al. (2015) Between-hospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med 372:1801-11|
|De Jesus, Lilia C; Sood, Beena G; Shankaran, Seetha et al. (2015) Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants. Am J Obstet Gynecol 212:94.e1-7|
Showing the most recent 10 out of 214 publications